Superficial basal cell carcinoma on face treated with 5% imiquimod cream
Imiquimod, an immune response modifier, is known to possess both anti-viral and anti-tumor effect. We report our experience of treating a large superficial spreading basal cell carcinoma with 5% imiquimod cream. A 65-year-old male had an asymptomatic, hyperpigmented, slowly progressive, indurated, 3...
Gespeichert in:
| Veröffentlicht in: | Indian journal of dermatology, venereology, and leprology venereology, and leprology, 2006-09, Vol.72 (5), p.373-375 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 375 |
|---|---|
| container_issue | 5 |
| container_start_page | 373 |
| container_title | Indian journal of dermatology, venereology, and leprology |
| container_volume | 72 |
| creator | Malhotra, Amit Kumar Bansal, Arika Mridha, Asit R Khaitan, Binod K Verma, Kaushal K |
| description | Imiquimod, an immune response modifier, is known to possess both anti-viral and anti-tumor effect. We report our experience of treating a large superficial spreading basal cell carcinoma with 5% imiquimod cream. A 65-year-old male had an asymptomatic, hyperpigmented, slowly progressive, indurated, 3 x 4 cm plaque on the left cheek for two months. Biopsy from the lesion showed features of basal cell carcinoma. The patient was treated with imiquimod 5% cream, topically three times a week for six months with complete resolution of the lesion and without any side-effects. There was no clinical or histological recurrence after three months of stopping the treatment. |
| doi_str_mv | 10.4103/0378-6323.27757 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_68968703</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A152664056</galeid><sourcerecordid>A152664056</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3867-e73b0556c27fdf4f893440123f3295b73b3786451e02e0e4f1dd65d5e04899e83</originalsourceid><addsrcrecordid>eNptkd1rFTEQxYMotlaffZNFaN_2NsnkY_NYirVCwQf1OeRmJ70pu5vbZBfxvzfrveIHJTAJmd8ZznAIecvoRjAKlxR01yrgsOFaS_2MnFKjoQXD-fP6_t09Ia9KeaCUCwXsJTlhmkpqQJ6S2y_LHnOIPrqh2bpSq8ehFpd9nNLomjQ1wXls5oxuxr75HuddI8-bOMbHJY6pb3ztjK_Ji-CGgm-O9xn5dvPh6_Vte_f546frq7vWQ6d0ixq2VErluQ59EKEzIARlHAJwI7e1Wz0rIRlSjhRFYH2vZC-Ris4Y7OCMXBzm7nN6XLDMdoxltewmTEuxqjOq0xQq-P4_8CEteareLDN1e6VhndYeoHs3oI1TSHN2_h4nzG5IE4ZYv6-Y5EoJKlXlN0_w9fQ4Rv-k4OIvwQ7dMO9KGpY5pqn8C14eQJ9TKRmD3ec4uvzDMmrXrO2apl3TtL-yrop3xwWX7Yj9H_4YLvwEvPefTg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>195096738</pqid></control><display><type>article</type><title>Superficial basal cell carcinoma on face treated with 5% imiquimod cream</title><source>MEDLINE</source><source>Bioline International</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Malhotra, Amit Kumar ; Bansal, Arika ; Mridha, Asit R ; Khaitan, Binod K ; Verma, Kaushal K</creator><creatorcontrib>Malhotra, Amit Kumar ; Bansal, Arika ; Mridha, Asit R ; Khaitan, Binod K ; Verma, Kaushal K</creatorcontrib><description>Imiquimod, an immune response modifier, is known to possess both anti-viral and anti-tumor effect. We report our experience of treating a large superficial spreading basal cell carcinoma with 5% imiquimod cream. A 65-year-old male had an asymptomatic, hyperpigmented, slowly progressive, indurated, 3 x 4 cm plaque on the left cheek for two months. Biopsy from the lesion showed features of basal cell carcinoma. The patient was treated with imiquimod 5% cream, topically three times a week for six months with complete resolution of the lesion and without any side-effects. There was no clinical or histological recurrence after three months of stopping the treatment.</description><identifier>ISSN: 0378-6323</identifier><identifier>EISSN: 0973-3922</identifier><identifier>EISSN: 1998-3611</identifier><identifier>DOI: 10.4103/0378-6323.27757</identifier><identifier>PMID: 17050935</identifier><language>eng</language><publisher>India: Medknow Publications and Media Pvt. Ltd</publisher><subject>Aged ; Aminoquinolines - administration & dosage ; Basal cell carcinoma ; Carcinoma, Basal Cell - diagnosis ; Carcinoma, Basal Cell - drug therapy ; Case studies ; Causes of ; Diagnosis ; Dosage and administration ; Drug therapy ; Face - pathology ; Humans ; Imiquimod ; Male ; Ointments ; Skin Neoplasms - diagnosis ; Skin Neoplasms - drug therapy</subject><ispartof>Indian journal of dermatology, venereology, and leprology, 2006-09, Vol.72 (5), p.373-375</ispartof><rights>COPYRIGHT 2006 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications Sep/Oct 2006</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3867-e73b0556c27fdf4f893440123f3295b73b3786451e02e0e4f1dd65d5e04899e83</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17050935$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Malhotra, Amit Kumar</creatorcontrib><creatorcontrib>Bansal, Arika</creatorcontrib><creatorcontrib>Mridha, Asit R</creatorcontrib><creatorcontrib>Khaitan, Binod K</creatorcontrib><creatorcontrib>Verma, Kaushal K</creatorcontrib><title>Superficial basal cell carcinoma on face treated with 5% imiquimod cream</title><title>Indian journal of dermatology, venereology, and leprology</title><addtitle>Indian J Dermatol Venereol Leprol</addtitle><description>Imiquimod, an immune response modifier, is known to possess both anti-viral and anti-tumor effect. We report our experience of treating a large superficial spreading basal cell carcinoma with 5% imiquimod cream. A 65-year-old male had an asymptomatic, hyperpigmented, slowly progressive, indurated, 3 x 4 cm plaque on the left cheek for two months. Biopsy from the lesion showed features of basal cell carcinoma. The patient was treated with imiquimod 5% cream, topically three times a week for six months with complete resolution of the lesion and without any side-effects. There was no clinical or histological recurrence after three months of stopping the treatment.</description><subject>Aged</subject><subject>Aminoquinolines - administration & dosage</subject><subject>Basal cell carcinoma</subject><subject>Carcinoma, Basal Cell - diagnosis</subject><subject>Carcinoma, Basal Cell - drug therapy</subject><subject>Case studies</subject><subject>Causes of</subject><subject>Diagnosis</subject><subject>Dosage and administration</subject><subject>Drug therapy</subject><subject>Face - pathology</subject><subject>Humans</subject><subject>Imiquimod</subject><subject>Male</subject><subject>Ointments</subject><subject>Skin Neoplasms - diagnosis</subject><subject>Skin Neoplasms - drug therapy</subject><issn>0378-6323</issn><issn>0973-3922</issn><issn>1998-3611</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkd1rFTEQxYMotlaffZNFaN_2NsnkY_NYirVCwQf1OeRmJ70pu5vbZBfxvzfrveIHJTAJmd8ZznAIecvoRjAKlxR01yrgsOFaS_2MnFKjoQXD-fP6_t09Ia9KeaCUCwXsJTlhmkpqQJ6S2y_LHnOIPrqh2bpSq8ehFpd9nNLomjQ1wXls5oxuxr75HuddI8-bOMbHJY6pb3ztjK_Ji-CGgm-O9xn5dvPh6_Vte_f546frq7vWQ6d0ixq2VErluQ59EKEzIARlHAJwI7e1Wz0rIRlSjhRFYH2vZC-Ris4Y7OCMXBzm7nN6XLDMdoxltewmTEuxqjOq0xQq-P4_8CEteareLDN1e6VhndYeoHs3oI1TSHN2_h4nzG5IE4ZYv6-Y5EoJKlXlN0_w9fQ4Rv-k4OIvwQ7dMO9KGpY5pqn8C14eQJ9TKRmD3ec4uvzDMmrXrO2apl3TtL-yrop3xwWX7Yj9H_4YLvwEvPefTg</recordid><startdate>20060901</startdate><enddate>20060901</enddate><creator>Malhotra, Amit Kumar</creator><creator>Bansal, Arika</creator><creator>Mridha, Asit R</creator><creator>Khaitan, Binod K</creator><creator>Verma, Kaushal K</creator><general>Medknow Publications and Media Pvt. Ltd</general><general>Scientific Scholar</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20060901</creationdate><title>Superficial basal cell carcinoma on face treated with 5% imiquimod cream</title><author>Malhotra, Amit Kumar ; Bansal, Arika ; Mridha, Asit R ; Khaitan, Binod K ; Verma, Kaushal K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3867-e73b0556c27fdf4f893440123f3295b73b3786451e02e0e4f1dd65d5e04899e83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Aged</topic><topic>Aminoquinolines - administration & dosage</topic><topic>Basal cell carcinoma</topic><topic>Carcinoma, Basal Cell - diagnosis</topic><topic>Carcinoma, Basal Cell - drug therapy</topic><topic>Case studies</topic><topic>Causes of</topic><topic>Diagnosis</topic><topic>Dosage and administration</topic><topic>Drug therapy</topic><topic>Face - pathology</topic><topic>Humans</topic><topic>Imiquimod</topic><topic>Male</topic><topic>Ointments</topic><topic>Skin Neoplasms - diagnosis</topic><topic>Skin Neoplasms - drug therapy</topic><toplevel>online_resources</toplevel><creatorcontrib>Malhotra, Amit Kumar</creatorcontrib><creatorcontrib>Bansal, Arika</creatorcontrib><creatorcontrib>Mridha, Asit R</creatorcontrib><creatorcontrib>Khaitan, Binod K</creatorcontrib><creatorcontrib>Verma, Kaushal K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Indian journal of dermatology, venereology, and leprology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Malhotra, Amit Kumar</au><au>Bansal, Arika</au><au>Mridha, Asit R</au><au>Khaitan, Binod K</au><au>Verma, Kaushal K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Superficial basal cell carcinoma on face treated with 5% imiquimod cream</atitle><jtitle>Indian journal of dermatology, venereology, and leprology</jtitle><addtitle>Indian J Dermatol Venereol Leprol</addtitle><date>2006-09-01</date><risdate>2006</risdate><volume>72</volume><issue>5</issue><spage>373</spage><epage>375</epage><pages>373-375</pages><issn>0378-6323</issn><eissn>0973-3922</eissn><eissn>1998-3611</eissn><abstract>Imiquimod, an immune response modifier, is known to possess both anti-viral and anti-tumor effect. We report our experience of treating a large superficial spreading basal cell carcinoma with 5% imiquimod cream. A 65-year-old male had an asymptomatic, hyperpigmented, slowly progressive, indurated, 3 x 4 cm plaque on the left cheek for two months. Biopsy from the lesion showed features of basal cell carcinoma. The patient was treated with imiquimod 5% cream, topically three times a week for six months with complete resolution of the lesion and without any side-effects. There was no clinical or histological recurrence after three months of stopping the treatment.</abstract><cop>India</cop><pub>Medknow Publications and Media Pvt. Ltd</pub><pmid>17050935</pmid><doi>10.4103/0378-6323.27757</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0378-6323 |
| ispartof | Indian journal of dermatology, venereology, and leprology, 2006-09, Vol.72 (5), p.373-375 |
| issn | 0378-6323 0973-3922 1998-3611 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68968703 |
| source | MEDLINE; Bioline International; EZB-FREE-00999 freely available EZB journals |
| subjects | Aged Aminoquinolines - administration & dosage Basal cell carcinoma Carcinoma, Basal Cell - diagnosis Carcinoma, Basal Cell - drug therapy Case studies Causes of Diagnosis Dosage and administration Drug therapy Face - pathology Humans Imiquimod Male Ointments Skin Neoplasms - diagnosis Skin Neoplasms - drug therapy |
| title | Superficial basal cell carcinoma on face treated with 5% imiquimod cream |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T18%3A11%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Superficial%20basal%20cell%20carcinoma%20on%20face%20treated%20with%205%25%20imiquimod%20cream&rft.jtitle=Indian%20journal%20of%20dermatology,%20venereology,%20and%20leprology&rft.au=Malhotra,%20Amit%20Kumar&rft.date=2006-09-01&rft.volume=72&rft.issue=5&rft.spage=373&rft.epage=375&rft.pages=373-375&rft.issn=0378-6323&rft.eissn=0973-3922&rft_id=info:doi/10.4103/0378-6323.27757&rft_dat=%3Cgale_proqu%3EA152664056%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=195096738&rft_id=info:pmid/17050935&rft_galeid=A152664056&rfr_iscdi=true |